QNME
What one share of Quanome Technologies holds
Arrangement of Transportation of Freight and Cargo
Prior to February 12, 2026, in addition to engaging in the distribution of pharmaceutical products through Hupan Pharmaceutical, we also operated as a U.S.-based integrated cross-border supply chain solutions provider with a strategic focus on the Asian market.
Quanome Technologies’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.23 |
|---|---|
| Profit | −$0.37 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.12 |
| Cash and investments | $0.02 |
| Debt | $0.00 |
| Book value | $0.20 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | $2.15 | $0.16 | $0.00 | $0.00 | — | $0.14 |
| 2024 | $3.05 | −$0.04 | — | −$0.01 | — | $0.11 |
| 2025 | $0.37 | −$0.69 | $0.00 | −$0.35 | — | $0.27 |
| 2026 | $0.23 | −$0.37 | $0.00 | −$0.12 | — | $0.20 |